D-0371-2022 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- January 19, 2022
- Initiation Date
- December 31, 2021
- Termination Date
- June 4, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,450 vials
Product Description
Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose Vials, 10 vials per carton, Rx Only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0703-1153-03.
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Methylprednisolone, TN Norepinephrine BItartrate - MS, OH
Code Information
Lot # 100020800, exp 07/2022